ClinicalTrials.gov
public full text
Public Domain
Effectiveness of Rifabutin for Treatment of Helicobacter Pylori
The aim of this study is to determine the effectiveness of rifabutin triple therapy for the treatment of H. pylori infection in the Israeli population. Patients with or without a prior history of H. pylori eradication failure will be randomized to receive one of three possible treatments: Group 1-amoxicillin 1000mg bd and rifabutin 150 mg bd and esomeprazole 40 mg bd Group 2- amoxicillin 1000mg bd and rifabutin 150 mg d and esomeprazole 40 mg bd Group 3- standard of care
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Safety and Efficacy Study of a Non-antibiotic Treatment for the Eradication of Helicobacter Pylori#181806
- A Multi-center Study for Eradication of Helicobacter Pylori With Triple Therapy Using Clarithromycin#300277
- Modified Non-clarithromycin Triple Therapy in Eradicating Helicobacter Pylori#810731
- Comparison Between Ten Days Sequential Treatment and Traditional Three Combined Treatment of Helicobacter Pylori#1163730
- Helicobacter Pylori Eradication With a New Sequential Treatment#853710
Record · ID 835686
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive